Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Joel Bierer"'
Autor:
Pantelis Andreou, John Sapp, Mark Henderson, David Horne, Joel Bierer, Roger Stanzel, Kristina Krmpotic, Jean S. Marshall
Publikováno v:
BMJ Open, Vol 14, Iss 8 (2024)
Introduction Surgical repair is the standard of care for most infants and children with congenital heart disease. Cardiopulmonary bypass (CPB) is required to facilitate these operations but elicits a systemic inflammatory response, leading to postope
Externí odkaz:
https://doaj.org/article/4325ae2406234b19901c7ff0e3072482
Autor:
Joel Bierer, Roger Stanzel, Mark Henderson, Suvro Sett, John Sapp, Pantelis Andreou, Jean S. Marshall, David Horne
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-12 (2023)
Abstract Background Cardiopulmonary bypass (CPB) is associated with systemic inflammation, featuring increased levels of circulating pro-inflammatory cytokines. Intra-operative ultrafiltration extracts fluid and inflammatory factors potentially dampe
Externí odkaz:
https://doaj.org/article/72e4bdc396a44a97a0de612399858024
Autor:
Richard A. Malthaner, Edward Yu, Michael Sanatani, Debra Lewis, Andrew Warner, A. Rashid Dar, Brian P. Yaremko, Joel Bierer, David A. Palma, Dalilah Fortin, Richard I. Inculet, Eric Fréchette, Jacques Raphael, Stewart Gaede, Sara Kuruvilla, Jawaid Younus, Mark D. Vincent, George B. Rodrigues
Publikováno v:
Thoracic Cancer, Vol 13, Iss 13, Pp 1898-1915 (2022)
Abstract Background We compared the health‐related quality of life (HRQOL) in patients undergoing trimodality therapy for resectable stage I‐III esophageal cancer. Methods A total of 96 patients were randomized to standard neoadjuvant cisplatin a
Externí odkaz:
https://doaj.org/article/3b12890c920c426ab850df2b1fe0356a
Autor:
Edward Yu, Alison L. Allan, Michael Sanatani, Debra Lewis, Andrew Warner, A. Rashid Dar, Brian P. Yaremko, Lori E. Lowes, David A. Palma, Jacques Raphael, Mark D. Vincent, George B. Rodrigues, Dalilah Fortin, Richard I. Inculet, Eric Frechette, Joel Bierer, Jeffery Law, Jawaid Younus, Richard A. Malthaner
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Our aim was to establish if presence of circulating tumor cells (CTCs) predicted worse outcome in patients with non-metastatic esophageal cancer undergoing tri-modality therapy. Methods We prospectively collected CTC data from pat
Externí odkaz:
https://doaj.org/article/8cb2db1ff05644bd83701d5be8c74a0a
Publikováno v:
Systematic Reviews, Vol 10, Iss 1, Pp 1-5 (2021)
Abstract Background Cardiac surgery with cardiopulmonary bypass (CPB) is associated with a systemic inflammatory syndrome that adversely impacts cardiopulmonary function and can contribute to prolonged postoperative recovery. Intra-operative ultrafil
Externí odkaz:
https://doaj.org/article/ae751f0eb9e14485bccf50b557215a14
Publikováno v:
CJC Open.
Autor:
Rachel Eikelboom, Subodh Verma, Ahmad Makhdoum, Olina Dagher, Olivier Vaillancourt, Gianluigi Bisleri, Terrence M. Yau, Nitish K. Dhingra, Andreanne Cartier, Jessica G.Y. Luc, Aathmika Kirubaharan, Bobby Yanagawa, Thin Xuan Vo, Keir Forgie, Joel Bierer
Publikováno v:
Journal of Cardiac Surgery. 36:2793-2801
BACKGROUND AND AIM The P2Y12 platelet receptor inhibitor ticagrelor is widely used in patients following acute coronary syndromes or in those who have received coronary stents. Bentracimab is a monoclonal antibody-based reversal agent that is being f
Publikováno v:
World Journal for Pediatric and Congenital Heart Surgery. 10:778-788
Introduction: The use of cardiopulmonary bypass in pediatric cardiac surgery is associated with significant inflammation, fluid overload, and end-organ dysfunction yielding morbidity and mortality. For decades, various intraoperative ultrafiltration
Publikováno v:
Perfusion. 37(8)
The use of cardiopulmonary bypass (CPB) can be associated with significant hemodilution, coagulopathy and a systemic inflammatory response for infants and children undergoing cardiac surgery. Intra-operative ultrafiltration has been used for decades
Autor:
Gianluigi Bisleri, Nitish K. Dhingra, Kier Forgie, Thin Xuan Vo, Terrence M. Yau, Jessica G.Y. Luc, Joel Bierer, Bobby Yanagawa, Andreanne Cartier, Rachel Eikelboom, Olina Dagher, Olivier Vaillancourt, Ahmed Makhdoum, Subodh Verma
Background and Aim: The P2Y12 platelet receptor inhibitor ticagrelor is widely used in patients following acute coronary syndromes or in those who have received coronary stents. Bentracimab is a monoclonal antibody-based reversal agent that is being
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::169e34b96f346560c66617c6b0a01ea9
https://doi.org/10.22541/au.161746912.20636917/v1
https://doi.org/10.22541/au.161746912.20636917/v1